$0.147900
0.00795.64%
At close: -
$0.149500
0.00161.08%
After Hours: 7:59 PM EDT
Comments
Loading...
Zomedica (AMEX:ZOM) Stock, Earnings Estimates, EPS, And Revenue
Zomedica reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 7
EPS
$-0.010
Quarterly Revenue
$7M
Annual Revenue
(as of Jun 30)
(as of Jun 30)
$26.1M
Analyze the earnings history of Zomedica using advanced sorting and filters.
Data brought to you by Benzinga APIs
Zomedica (ZOM) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Dec 2022 | 2023-03-15 | $-0.01 | $-0.01 | 40.0 % |
Zomedica (ZOM) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Jun 2024 | 2024-08-14 | $6.13M | $6.26M | -2.06 % |
| Mar 2024 | 2024-05-09 | $6.26M | $8.18M | -23.4 % |
| Mar 2024 | 2024-04-01 | $7.34M | $7.00M | 4.81 % |
| Sep 2023 | 2023-11-13 | $6.35M | $8.28M | -23.4 % |
FAQ
When is Zomedica (AMEX:ZOM) reporting earnings?
Zomedica ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 7, 2024 for Q3.
What were the latest earnings per share (EPS) for Zomedica (AMEX:ZOM)?
Zomedica ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 7, 2024 for Q3 and the Actual EPS was $-0.01, which missed the estimate of $0.00.
What were Zomedica’s (AMEX:ZOM) revenues?
Zomedica ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 7, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which beat the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.